SIHUAN PHARM(00460): Innovative drug Genaton included in the national basic medical insurance drug list for the first time.

SIHUAN PHARM (00460) announced that its subsidiary Xuanzhu Bio-Technology Co., Ltd. (Xuanzhu Bio) has independently developed the innovative drug Piroxicam tablets (trade name: Xuan Yu Ning), which has been included for the first time in the "National List of Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drugs (2025)" (2025 National Basic Medical Insurance List). The 2025 National Basic Medical Insurance List will be officially implemented on January 1, 2026. The results of this medical insurance negotiation will help Xuanzhu Bio further enhance the affordability and accessibility of Xuan Yu Ning among patients, and it is conducive to further promoting the market expansion and increasing sales volume of this drug, which will have a positive impact on Xuanzhu Bio's long-term business development. Xuanzhu Bio will actively cooperate to promote the implementation of medical insurance policies, continue to advance hospital access work, expand coverage in core markets and broader markets, in order to continuously improve the accessibility of medication for patients.